Drug Profile
Citalopram controlled release - Lundbeck A/S/Bausch Health Companies
Latest Information Update: 10 Dec 2021
Price :
$50
*
At a glance
- Originator Lundbeck A/S
- Developer Bausch Health Companies; Lundbeck A/S
- Class Antidepressants; Benzofurans; Nitriles; Propylamines; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Depressive disorders
Most Recent Events
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies